Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL972924 | 0.95 | MEN1 (0.73) | MEN1LMNACYP3A4KMT2A | |
| SCHEMBL190974 | 0.95 | MEN1 (0.73) | MEN1LMNACYP3A4KMT2A | |
| Oseltamivir SCHEMBL455879 | 0.91 | MEN1 (0.81) | MEN1LMNACYP3A4KMT2A | |
| Oseltamivir SCHEMBL29085770 | 0.91 | MEN1 (0.81) | MEN1LMNACYP3A4KMT2A | |
| Oseltamivir SCHEMBL18117995 | 0.91 | MEN1 (0.81) | MEN1LMNACYP3A4KMT2A | |
| Oseltamivir SCHEMBL15912673 | 0.91 | MEN1 (0.81) | MEN1LMNACYP3A4KMT2A | |
| Oseltamivir SCHEMBL8730 | 0.91 | MEN1 (0.81) | MEN1LMNACYP3A4KMT2A | |
| Oseltamivir SCHEMBL28613342 | 0.90 | MEN1 (0.80) | MEN1LMNACYP3A4KMT2A | |
| Oseltamivir Carboxylate SCHEMBL3079392 | 0.90 | — | — | |
| SCHEMBL974858 | 0.88 | MEN1 (0.67) | MEN1LMNACYP3A4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116699013-A | Method for separating and detecting related impurities in oseltamium phosphate Wei Kou disintegrating tablet | 北京星昊医药股份有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-118680917-B | Oseltamivir phosphate-containing composition and application thereof in preparation of antiviral drugs | 衡阳市中心医院 | 2025-05-13 | — | — | CN | disclosed |
| CN-119385967-A | Oseltamivir phosphate-containing capsule and application thereof | 山东新时代药业有限公司 | 2025-02-07 | — | — | CN | disclosed |
| CN-118680917-A | Oseltamivir phosphate-containing composition and application thereof in preparation of antiviral drugs | 衡阳市中心医院 | 2024-09-24 | — | — | CN | disclosed |
| CN-117860726-A | Oseltamivir phosphate solid preparation and preparation process thereof | 浙江高跖医药科技股份有限公司 | 2024-04-12 | — | — | CN | disclosed |
| CN-116699013-A | Method for separating and detecting related impurities in oseltamium phosphate Wei Kou disintegrating tablet | 北京星昊医药股份有限公司 | 2023-09-05 | — | — | CN | disclosed |
| EP-2240433-B1 | POLYMORPHIC FORMS OF OSELTAMIVIR PHOSPHATE | HOFFMANN LA ROCHE (CH) | 2013-03-20 | — | — | EP | disclosed |